Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions

Hafiz Muhammad Sharjeel Arshad, Sheila Bharmal, Deniz Guney Duman, Suthat Liangpunsakul, Brian G. Turner

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Pancreatic cystic lesions can be benign, premalignant or malignant. The recent increase in detection and tremendous clinical variability of pancreatic cysts has presented a significant therapeutic challenge to physicians. Mucinous cystic neoplasms are of particular interest given their known malignant potential. This review article provides a brief but comprehensive review of premalignant pancreatic cystic lesions with advanced endoscopic ultrasound (EUS) management approaches. A comprehensive literature search was performed using PubMed, Cochrane, OVID and EMBASE databases. Preneoplastic pancreatic cystic lesions include mucinous cystadenoma and intraductal papillary mucinous neoplasm. The 2012 International Sendai Guidelines guide physicians in their management of pancreatic cystic lesions. Some of the advanced EUS management techniques include ethanol ablation, chemotherapeutic (paclitaxel) ablation, radiofrequency ablation and cryotherapy. In future, EUS-guided injections of drug-eluting beads and neodymium:yttrium aluminum agent laser ablation is predicted to be an integral part of EUS-guided management techniques. In summary, International Sendai Consensus Guidelines should be used to make a decision regarding management of pancreatic cystic lesions. Advanced EUS techniques are proving extremely beneficial in management, especially in those patients who are at high surgical risk.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalJournal of Investigative Medicine
Volume65
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Ultrasonics
Mucinous Cystadenoma
Pancreatic Cyst
Guidelines
Physicians
Neodymium
Yttrium
Cryotherapy
Laser Therapy
Ablation
Paclitaxel
Aluminum
PubMed
Neoplasms
Ethanol
Databases
Injections
Pharmaceutical Preparations
Laser ablation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions. / Arshad, Hafiz Muhammad Sharjeel; Bharmal, Sheila; Duman, Deniz Guney; Liangpunsakul, Suthat; Turner, Brian G.

In: Journal of Investigative Medicine, Vol. 65, No. 1, 01.01.2017, p. 7-14.

Research output: Contribution to journalReview article

Arshad, Hafiz Muhammad Sharjeel ; Bharmal, Sheila ; Duman, Deniz Guney ; Liangpunsakul, Suthat ; Turner, Brian G. / Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions. In: Journal of Investigative Medicine. 2017 ; Vol. 65, No. 1. pp. 7-14.
@article{05e76d8c765645a7a9e8f10b1e86e0ba,
title = "Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions",
abstract = "Pancreatic cystic lesions can be benign, premalignant or malignant. The recent increase in detection and tremendous clinical variability of pancreatic cysts has presented a significant therapeutic challenge to physicians. Mucinous cystic neoplasms are of particular interest given their known malignant potential. This review article provides a brief but comprehensive review of premalignant pancreatic cystic lesions with advanced endoscopic ultrasound (EUS) management approaches. A comprehensive literature search was performed using PubMed, Cochrane, OVID and EMBASE databases. Preneoplastic pancreatic cystic lesions include mucinous cystadenoma and intraductal papillary mucinous neoplasm. The 2012 International Sendai Guidelines guide physicians in their management of pancreatic cystic lesions. Some of the advanced EUS management techniques include ethanol ablation, chemotherapeutic (paclitaxel) ablation, radiofrequency ablation and cryotherapy. In future, EUS-guided injections of drug-eluting beads and neodymium:yttrium aluminum agent laser ablation is predicted to be an integral part of EUS-guided management techniques. In summary, International Sendai Consensus Guidelines should be used to make a decision regarding management of pancreatic cystic lesions. Advanced EUS techniques are proving extremely beneficial in management, especially in those patients who are at high surgical risk.",
author = "Arshad, {Hafiz Muhammad Sharjeel} and Sheila Bharmal and Duman, {Deniz Guney} and Suthat Liangpunsakul and Turner, {Brian G.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1136/jim-2016-000167",
language = "English (US)",
volume = "65",
pages = "7--14",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions

AU - Arshad, Hafiz Muhammad Sharjeel

AU - Bharmal, Sheila

AU - Duman, Deniz Guney

AU - Liangpunsakul, Suthat

AU - Turner, Brian G.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Pancreatic cystic lesions can be benign, premalignant or malignant. The recent increase in detection and tremendous clinical variability of pancreatic cysts has presented a significant therapeutic challenge to physicians. Mucinous cystic neoplasms are of particular interest given their known malignant potential. This review article provides a brief but comprehensive review of premalignant pancreatic cystic lesions with advanced endoscopic ultrasound (EUS) management approaches. A comprehensive literature search was performed using PubMed, Cochrane, OVID and EMBASE databases. Preneoplastic pancreatic cystic lesions include mucinous cystadenoma and intraductal papillary mucinous neoplasm. The 2012 International Sendai Guidelines guide physicians in their management of pancreatic cystic lesions. Some of the advanced EUS management techniques include ethanol ablation, chemotherapeutic (paclitaxel) ablation, radiofrequency ablation and cryotherapy. In future, EUS-guided injections of drug-eluting beads and neodymium:yttrium aluminum agent laser ablation is predicted to be an integral part of EUS-guided management techniques. In summary, International Sendai Consensus Guidelines should be used to make a decision regarding management of pancreatic cystic lesions. Advanced EUS techniques are proving extremely beneficial in management, especially in those patients who are at high surgical risk.

AB - Pancreatic cystic lesions can be benign, premalignant or malignant. The recent increase in detection and tremendous clinical variability of pancreatic cysts has presented a significant therapeutic challenge to physicians. Mucinous cystic neoplasms are of particular interest given their known malignant potential. This review article provides a brief but comprehensive review of premalignant pancreatic cystic lesions with advanced endoscopic ultrasound (EUS) management approaches. A comprehensive literature search was performed using PubMed, Cochrane, OVID and EMBASE databases. Preneoplastic pancreatic cystic lesions include mucinous cystadenoma and intraductal papillary mucinous neoplasm. The 2012 International Sendai Guidelines guide physicians in their management of pancreatic cystic lesions. Some of the advanced EUS management techniques include ethanol ablation, chemotherapeutic (paclitaxel) ablation, radiofrequency ablation and cryotherapy. In future, EUS-guided injections of drug-eluting beads and neodymium:yttrium aluminum agent laser ablation is predicted to be an integral part of EUS-guided management techniques. In summary, International Sendai Consensus Guidelines should be used to make a decision regarding management of pancreatic cystic lesions. Advanced EUS techniques are proving extremely beneficial in management, especially in those patients who are at high surgical risk.

UR - http://www.scopus.com/inward/record.url?scp=85019102758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019102758&partnerID=8YFLogxK

U2 - 10.1136/jim-2016-000167

DO - 10.1136/jim-2016-000167

M3 - Review article

VL - 65

SP - 7

EP - 14

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 1

ER -